FYI
On January 31, 2025, BlackRock, Inc. (Trades, Portfolio) executed a significant transaction by acquiring an additional 7,083,925 shares of ACADIA Pharmaceuticals Inc. This acquisition was made at a trade price of $18.66 per share, bringing BlackRock's total holdings in ACADIA Pharmaceuticals to 19,878,746 shares. This move reflects BlackRock's strategic interest in the biotechnology sector, particularly in companies focusing on central nervous system disorders. The transaction did not impact BlackRock's overall portfolio, maintaining its position at 0.01% of the firm's total equity.
Kens
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $14.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.23 | 3278 | 1 |
View Market Depth
| Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |